0 Valutazioni

ID

15398

Descrizione

Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02260414

collegamento

https://clinicaltrials.gov/show/NCT02260414

Keywords

  1. 30/05/16 30/05/16 -
Caricato su

30 maggio 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :


    Non ci sono commenti

    Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

    Eligibility Lymphoma NCT02260414

    Eligibility Lymphoma NCT02260414

    1. StudyEvent: Eligibility
      1. Eligibility Lymphoma NCT02260414
    Inclusion Criteria
    Descrizione

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    1. body weight between 40 and 100 kg
    Descrizione

    Body Weight

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0005910
    2. patient:
    Descrizione

    Patient

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0030705
    2a- with multiple myeloma indication with de novo standard treatment thalidomide or lenalidomide or erythropoietin (group 1) 2b- or hospitalized for aggressive lymphoma treated with chemotherapy (group 2) 2c- or older than 40 years and hospitalized at least three days for an acute medical pathology type of acute respiratory or cardiac (group 3) decompensation
    Descrizione

    Lymphoma stage | Indication Multiple Myeloma | Therapeutic procedure Thalidomide | Therapeutic procedure lenalidomide | Therapeutic procedure Erythropoietin | Hospitalization | Aggressive Non-Hodgkin Lymphoma | Chemotherapy Regimen | Age | Acute respiratory decompensation | Heart Decompensation

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C1272836
    UMLS CUI [2,1]
    C3146298
    UMLS CUI [2,2]
    C0026764
    UMLS CUI [3,1]
    C0087111
    UMLS CUI [3,2]
    C0039736
    UMLS CUI [4,1]
    C0087111
    UMLS CUI [4,2]
    C1144149
    UMLS CUI [5,1]
    C0087111
    UMLS CUI [5,2]
    C0014822
    UMLS CUI [6]
    C0019993
    UMLS CUI [7]
    C1332225
    UMLS CUI [8]
    C0392920
    UMLS CUI [9]
    C0001779
    UMLS CUI [10]
    C0748352
    UMLS CUI [11]
    C1961112
    Exclusion Criteria
    Descrizione

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    patient requiring anticoagulant therapy at curative doses
    Descrizione

    Anticoagulant therapy Curative

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1,1]
    C0150457
    UMLS CUI [1,2]
    C1880198
    patients with a lower platelet count 80 g / l
    Descrizione

    Decreased platelet count

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0392386
    subject with a history of heparin-induced thrombocytopenia
    Descrizione

    Heparin-induced thrombocytopenia

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0272285
    subject with a history of hemorrhagic disease
    Descrizione

    Hemorrhagic Disorders

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0019087
    history of severe trauma within 6 weeks prior to enrollment
    Descrizione

    Trauma Severe

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1,1]
    C3714660
    UMLS CUI [1,2]
    C0205082
    organic lesion at risk of bleeding
    Descrizione

    Lesion Organ

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1,1]
    C0221198
    UMLS CUI [1,2]
    C0178784
    poor renal with creatinine clearance <30 ml / min
    Descrizione

    Abnormal renal function | Creatinine clearance measurement

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0151746
    UMLS CUI [2]
    C0373595
    hypersensitivity to tinzaparin
    Descrizione

    Hypersensitivity tinzaparin

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C0216278
    events or bleeding tendencies associated with coagulation disorders
    Descrizione

    Event Associated with Blood Coagulation Disorders | Bleeding tendency Associated with Blood Coagulation Disorders

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1,1]
    C0441471
    UMLS CUI [1,2]
    C0332281
    UMLS CUI [1,3]
    C0005779
    UMLS CUI [2,1]
    C1458140
    UMLS CUI [2,2]
    C0332281
    UMLS CUI [2,3]
    C0005779
    subject on oral anticoagulant
    Descrizione

    oral anticoagulants

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0354604
    for group 3: presence of hematological malignancy or active cancer
    Descrizione

    Hematologic Neoplasms | Malignant Neoplasms

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0376545
    UMLS CUI [2]
    C0006826

    Similar models

    Eligibility Lymphoma NCT02260414

    1. StudyEvent: Eligibility
      1. Eligibility Lymphoma NCT02260414
    Name
    genere
    Description | Question | Decode (Coded Value)
    Tipo di dati
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Body Weight
    Item
    1. body weight between 40 and 100 kg
    boolean
    C0005910 (UMLS CUI [1])
    Patient
    Item
    2. patient:
    boolean
    C0030705 (UMLS CUI [1])
    Lymphoma stage | Indication Multiple Myeloma | Therapeutic procedure Thalidomide | Therapeutic procedure lenalidomide | Therapeutic procedure Erythropoietin | Hospitalization | Aggressive Non-Hodgkin Lymphoma | Chemotherapy Regimen | Age | Acute respiratory decompensation | Heart Decompensation
    Item
    2a- with multiple myeloma indication with de novo standard treatment thalidomide or lenalidomide or erythropoietin (group 1) 2b- or hospitalized for aggressive lymphoma treated with chemotherapy (group 2) 2c- or older than 40 years and hospitalized at least three days for an acute medical pathology type of acute respiratory or cardiac (group 3) decompensation
    boolean
    C1272836 (UMLS CUI [1])
    C3146298 (UMLS CUI [2,1])
    C0026764 (UMLS CUI [2,2])
    C0087111 (UMLS CUI [3,1])
    C0039736 (UMLS CUI [3,2])
    C0087111 (UMLS CUI [4,1])
    C1144149 (UMLS CUI [4,2])
    C0087111 (UMLS CUI [5,1])
    C0014822 (UMLS CUI [5,2])
    C0019993 (UMLS CUI [6])
    C1332225 (UMLS CUI [7])
    C0392920 (UMLS CUI [8])
    C0001779 (UMLS CUI [9])
    C0748352 (UMLS CUI [10])
    C1961112 (UMLS CUI [11])
    Item Group
    C0680251 (UMLS CUI)
    Anticoagulant therapy Curative
    Item
    patient requiring anticoagulant therapy at curative doses
    boolean
    C0150457 (UMLS CUI [1,1])
    C1880198 (UMLS CUI [1,2])
    Decreased platelet count
    Item
    patients with a lower platelet count 80 g / l
    boolean
    C0392386 (UMLS CUI [1])
    Heparin-induced thrombocytopenia
    Item
    subject with a history of heparin-induced thrombocytopenia
    boolean
    C0272285 (UMLS CUI [1])
    Hemorrhagic Disorders
    Item
    subject with a history of hemorrhagic disease
    boolean
    C0019087 (UMLS CUI [1])
    Trauma Severe
    Item
    history of severe trauma within 6 weeks prior to enrollment
    boolean
    C3714660 (UMLS CUI [1,1])
    C0205082 (UMLS CUI [1,2])
    Lesion Organ
    Item
    organic lesion at risk of bleeding
    boolean
    C0221198 (UMLS CUI [1,1])
    C0178784 (UMLS CUI [1,2])
    Abnormal renal function | Creatinine clearance measurement
    Item
    poor renal with creatinine clearance <30 ml / min
    boolean
    C0151746 (UMLS CUI [1])
    C0373595 (UMLS CUI [2])
    Hypersensitivity tinzaparin
    Item
    hypersensitivity to tinzaparin
    boolean
    C0020517 (UMLS CUI [1,1])
    C0216278 (UMLS CUI [1,2])
    Event Associated with Blood Coagulation Disorders | Bleeding tendency Associated with Blood Coagulation Disorders
    Item
    events or bleeding tendencies associated with coagulation disorders
    boolean
    C0441471 (UMLS CUI [1,1])
    C0332281 (UMLS CUI [1,2])
    C0005779 (UMLS CUI [1,3])
    C1458140 (UMLS CUI [2,1])
    C0332281 (UMLS CUI [2,2])
    C0005779 (UMLS CUI [2,3])
    oral anticoagulants
    Item
    subject on oral anticoagulant
    boolean
    C0354604 (UMLS CUI [1])
    Hematologic Neoplasms | Malignant Neoplasms
    Item
    for group 3: presence of hematological malignancy or active cancer
    boolean
    C0376545 (UMLS CUI [1])
    C0006826 (UMLS CUI [2])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial